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Sean Michael Carroll1, Katherine S Xue2 and Christopher J Marx1,3*Abstract
Background: A common assumption of microorganisms is that laboratory stocks will remain genetically and
phenotypically constant over time, and across laboratories. It is becoming increasingly clear, however, that
mutations can ruin strain integrity and drive the divergence or “domestication” of stocks. Since its discovery in 1960,
a stock of Methylobacterium extorquens AM1 (“AM1”) has remained in the lab, propagated across numerous growth
and storage conditions, researchers, and facilities. To explore the extent to which this lineage has diverged, we
compared our own “Modern” stock of AM1 to a sample archived at a culture stock center shortly after the strain’s
discovery. Stored as a lyophilized sample, we hypothesized that this Archival strain would better reflect the first-ever
isolate of AM1 and reveal ways in which our Modern stock has changed through laboratory domestication or
other means.
Results: Using whole-genome re-sequencing, we identified some 29 mutations – including single nucleotide
polymorphisms, small indels, the insertion of mobile elements, and the loss of roughly 36 kb of DNA - that arose
in the laboratory-maintained Modern lineage. Contrary to our expectations, Modern was both slower and less fit
than Archival across a variety of growth substrates, and showed no improvement during long-term growth and
storage. Modern did, however, outperform Archival during growth on nutrient broth, and in resistance to rifamycin,
which was selected for by researchers in the 1980s. Recapitulating selection for rifamycin resistance in replicate Archival
populations showed that mutations to RNA polymerase B (rpoB) substantially decrease growth in the absence of
antibiotic, offering an explanation for slower growth in Modern stocks. Given the large number of genomic
changes arising from domestication (28), it is somewhat surprising that the single other mutation attributed to
purposeful laboratory selection accounts for much of the phenotypic divergence between strains.
Conclusions: These results highlight the surprising degree to which AM1 has diverged through a combination
of unintended laboratory domestication and purposeful selection for rifamycin resistance. Instances of strain
divergence are important, not only to ensure consistency of experimental results, but also to explore how
microbes in the lab diverge from one another and from their wild counterparts.
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To ensure that scientific results are both reproducible
and consistent, a high level of integrity is required of ex-
perimental methods and microbial stocks. One assump-
tion is that stocks are constant over time, such that
contemporary isolates of a given strain are genetically
and physiologically identical across laboratories, and to
stocks from many years ago. However, before the wide-
spread use of deep freezers or lyophilization, storage of
stocks using agar slants and other methods permitted
growth and metabolism, albeit slowly, over long periods
of time. And as long as stocks are metabolically active,
mutations are likely to appear. If these mutations are
beneficial, they can be enriched or fixed in stocks and
subsequent sub-cultures via natural selection; or, alterna-
tively, practices such as plate streaking and colony pick-
ing could inadvertently propagate clones with neutral or
even deleterious mutations due to random sampling or
“genetic drift”. Either way, such mutations are the bane
of microbial stocks: they destroy the integrity of other-
wise isogenic lines, and they become the raw material
for processes such as selection and drift to facilitate evo-
lutionary divergence in strains over time.
The slow accrual of mutations often goes unnoticed in
laboratory strains, but can result in considerable genomic
and phenotypic differences both between independent la-
boratory stocks, and between laboratory strains and their
wild counterparts. This unintended mutational divergence
is termed “laboratory domestication”, and is particularly
common in many (if not most) microorganisms isolated
prior to the widespread use of modern storage methods
(e.g., cryopreservation in deep freezers or lyophilization).
For example, the domestication of Bacillus subtilis to the
lab is associated with a loss of biofilms [1], swarming be-
havior [2], and fruiting body formation (sporulation) [3].
Stocks of Salmonella enterica serovar Typhimurium [4,5]
and Escherichia coli [6-8] archived for years or decades
show a considerable amount of genetic diversity and novel
phenotypes stemming from long-term growth and sur-
vival during storage in agar stabs. Other controlled studies
of microbes from the lab [9,10] or the wild [11-13] also
show how growth, storage, and passaging procedures can
readily lead to the diversification, divergence, and domes-
tication of stocks. Outside of microbes, examples of do-
mestication have been documented in stocks of the
nematode worm, C. elegans [14,15], and in independent
stocks of laboratory mice [16,17]. In all these examples,
understanding the extent to which laboratory domestica-
tion has occurred is important - not only for the
standardization of experiments and the correct inter-
pretation of results - but also because each instance of
domestication is itself an interesting case-study of gen-
omic and phenotypic divergence driven by a subtle and
often cryptic set of evolutionary processes.Since the early 1960s, Methylobacterium extorquens
AM1 has emerged as the predominant model system for
studies of bacterial one-carbon metabolism. As a faculta-
tive methylotroph, M. extorquens AM1 (herein referred
to as “AM1”) has the ability to grow using reduced one-
carbon (C1) compounds such as methanol and methyl-
amine as the sole source of carbon and energy, as well
as multi-carbon (multi-C) compounds such as succinate,
pyruvate, and acetate [18,19]. The oxidation of methanol
into biomass proceeds via the highly toxic intermediate,
formaldehyde, and is complex, requiring over 100 en-
zymes [20]. A sequenced genome [21], genetic tools
[22-26], optimized growth conditions [27], metabolic
models [28], and extensive knowledge of both C1 and
multi-C metabolism [29] all make AM1 the ideal organ-
ism for studies of methylotrophy in the lab, as well as an
emerging system for experimental evolution [30-33].
Aside from AM1, related methylobacteria are known for
their roles in the plant microbiome [34-37], the biodeg-
radation of toxic chemicals like chloromethane [38] and
dichloromethane [39], and their potential for use in in-
dustrial applications [40,41].
Unlike most organisms, the discovery and establishment
of AM1 as a model system was completely accidental.
Around the year 1960, Dr. J.R. Quayle and colleagues at
the University of Oxford were searching for a new organ-
ism in which to study the oxidation and assimilation of C1
compounds, but discovered in their medium a “heavy,
pink growth, presumably due to some airborne contamin-
ant” [18,42]. After the contaminant was isolated, it was
found to grow rapidly on a variety of both C1 and multi-C
compounds. Shortly thereafter, a sample of AM1 - then
known as Pseudomonas AM1 for “Airborne Methylo-
troph #1” - was deposited to the National Collection of
Industrial and Marine Bacteria (NCIMB, Aberdeen,
Scotland), while a working stock remained in the lab.
Over the years, this working stock was maintained and
propagated between different researchers, laboratories,
and growth and storage conditions, all the way up to our
own laboratory’s stock. These circumstances raise the
question: to what extent has this AM1 lineage diverged
during its time in the lab?
To address this question, we sought to compare to-
day’s AM1 to its ancestor isolated circa 1960, or a close
descendent of this ancestor. Closely related strains of
M. extorquens differ significantly in their gene content
and metabolic capabilities [43], making these a less
than ideal comparison to determine the ancestral “wild”
AM1 state. Luckily, however, we realized that two major
lineages of AM1 were established circa 1960: the stock ar-
chived circa 1961 at the culture stock center (herein re-
ferred to as the “Archival” strain); and the working line of
AM1 that was propagated over many years from J.R.
Quayle’s lab, to Mary Lidstrom’s group, to our own
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pothesized that the Archival AM1 – which underwent
longer periods of lyophilized storage with fewer growth
cycles in between – might better-reflect the ancestral state
of AM1 circa 1960, and offer an excellent reference with
which to identify evolutionary divergence in the laboratory-
maintained AM1 lineage. We document here the surprising
extent to which our Modern AM1 has changed during its
time in the lab using various assays of growth and fitness,
long-term growth and storage, and whole-genome sequen-
cing of the Archival AM1 strain. We then offer a discussion
of specific laboratory practices and evolutionary processes
that may have led to such divergence.
Results
Whole-genome sequencing reveals extensive genomic
divergence in the Modern AM1 lineage
To explore the extent to which AM1 has diverged at the
genomic level, we used whole-genome sequencing to
compare the Archival genome to a previously sequenced
Modern reference [21]. Illumina sequencing reads were
analyzed both by mapping onto the Modern reference,
and through de novo sequence assembly. For sites in
which these strains differed, we compared the muta-
tional state at each site (i.e., Archival or Modern) to
other previously sequenced strains of M. extorquens to
determine whether substitutions occurred in either the
Modern or Archival lineage (Figure 1). While this ana-
lysis cannot identify changes that occurred between the
divergence of “wild” AM1 from the Archival/Modern la-
boratory ancestor, these mutations, if any, would only
add to the ways in which AM1 has evolved in the lab.
Our results identified a sizeable number and variety of
mutations that separate the Modern and Archival strains.
We discovered 11 SNPs, 4 small indels (1–5 bp), the pro-
liferation of 9 insertion sequence (mobile) elements, and
some 36 kb of DNA found in 5 de novo assembled contigs
that are present in the Archival strain but absent in
Modern AM1 (Table 1). For all but two of these muta-
tions, excluding DNA loss, the Archival state is universallyFigure 1 Two distinct lineages of Methylobacterium extorquens AM1.
(“AM1”) was deposited to a culture stock center for storage and distribution
stock of AM1 that was maintained over fifty years in the lab (3; Modern AM
We hypothesized that these conditions may have fostered the accumulatio
Modern AM1 lineage, and sought to compare our Modern AM1 to the Arc
Modern lineage.conserved with related M. extorquens strains to the exclu-
sion of Modern AM1. Taken together, these results
strongly suggest that this extensive genomic divergence oc-
curred solely in the Modern AM1 lineage, while the Arch-
ival AM1 has been largely preserved.
Some Modern mutations are likely to have far-reaching
physiological consequences. Certain mutations target
highly pleiotropic genes such as rplJ, which encodes
the ribosomal subunit protein L10; rpoB, the beta sub-
unit of RNA polymerase; and recG, the primary DNA
helicase involved in recombination repair and other
functions. The insertion of mobile elements might also
have altered physiology in the evolution of Modern
AM1, jumping into several putative protein-coding
genes. Still other mutations resulted in the loss of a
substantial amount of DNA from Archival to Modern
AM1. Deleted regions were typically flanked by inser-
tion sequences and other low complexity DNA, but in
most instances we could infer the likely genomic loca-
tion and content of these deletions (Table 1). Those
genes deleted in Modern AM1 are predicted to perform a
variety of functions, and appear in some instances to be
homologs of genes found only in distantly related mem-
bers of the Methylobacterium genus. Further insights into
the extensive loss of DNA in Modern AM1, as well as the
functional and evolutionary consequences of Modern mu-
tations, will require considerable future work. Still, these
results clearly show that the Modern AM1 lineage has
undergone a substantial degree of evolutionary divergence
and domestication over fifty years of growth and storage
in the lab.
Archival is faster and fitter under most standard
growth conditions
To begin to explore the phenotypic differences arising in
Modern AM1, we compared the performance of Modern
and Archival strains grown on standard growth sub-
strates in “Hypho” minimal medium. Two primary met-
rics were used to assess growth: specific growth rate,
determined from the increase in optical density (OD600)Shortly after its discovery in 1960 (1), a sample of M. extorquens AM1
(2; Archival AM1). Many researchers, however, use instead a working
1), and was at one point selected for rifamycin resistance (RifR) [45].
n of mutations and unintended evolutionary divergence in the
hival strain. Dashes represent the accumulation of mutations in the
Table 1 List of mutations derived in the Modern AM1 lineage
Single nucleotide polymorphisms
Chromosome Position Mutation Annotation Gene/Locus Description
META1 611,700 G→A Intergenic (+342/-18) META1_0578/META1_0579 Transcriptional accessory protein/
hypothetical protein
META1 2,050,899 G→C S359R (AGG→ AGC) META1_1984 Putative catecholate siderophore
receptor fiu precursor (TonB-
dependent receptor fiu)
META1 2,511,236 C→ T L8004F (CTC→ TTC) META1_2412 Hypothetical protein
META1 3,795,848 C→ T L264F (CTC→ TTC) aldB Aldehyde dehydrogenase;
chloroacetaldehyde dehydrogenase
META1 4,123,848 C→ T Intergenic (-1754/+2180) META1_4038/rffH Fragment of transposase related to
IS701 family/glucose-1-phosphate
thymidylyltransferase
META1 4,382,526 C→G T160T (ACC→ACG) META1_4292 Plasmid replication protein RepA
META1 4,494,119 A→G N55D (AAC→GAC) rplJ 50S ribosomal subunit protein L10
META1 4,496,733 A→G Q521R (CAG→CGG) rpoB RNA polymerase, beta subunit
META1 4,498,413 A→G Q1081R (CAG→CGG) rpoB RNA polymerase, beta subunit
META1 4,665,003 C→ A L300M (CTG→ATG) recG DNA helicase, ATP-dependent
resolution of Holliday junctions,
branch migration
META1 5,187,175 G→ A A260T (GCC→ACC) META1_5044 Putative o-succinylbenzoate--
CoA ligase
Small insertions & deletions
Chromosome Position Mutation Annotation Gene/Locus Description
META1 1,083,921 +1 bp Intergenic (-299/+188) META1_1041/META1_1042 Putative CoxB/conserved
hypothetical protein
META1 2,012,135 +5 bp Coding (126-130/228 nt) META1_1939 Hypothetical protein
META1 5,018,430 Δ1 bp Intergenic (-120/+218) META1_4900/META1_4901 Putative hydrolase of beta-lactamase
superfamily/conserved hypothetical
protein DUF949
META2 821,910 +1 bp Intergenic (+133/-26) META2_0863/META2_0864 AAA superfamily ATPase/
hypothetical protein
IS elements
Chromosome Position Mutation Annotation Gene/Locus Description
META1 772,350 +1408 bp Gain ISMex3; coding META1_0742–META1_0743 META1_0742, META1_0743
META1 929,023 +1390 bp Gain ISMex14; intergenic META1_0895-META1_0898 Transposase of ISMex1, IS3 family
(ORF 1)/transposase of ISMex14,
IS256 family
META1 3,730,805 +1408 bp Gain ISMex3; coding META1_3592–META1_CDS3732187D META1_3592, META1_3593,
META1_CDS3732187D
META1 4,143,329 +1620 bp Gain ISMex4; intergenic META1_4059-META1_4061 Hypothetical protein/transposase of
ISMex4, IS1380 family
META1 4,149,803 +1408 bp Gain ISMex3; coding META1_4069 META1_4069
META1 4,702,223 +1620 bp Gain ISMex4; intergenic META1_4586-META1_CDS4704205D Transposase of ISMex4, IS1380
family/hypothetical protein;
RMQ08497
META1 4,909,262 +1620 bp Gain ISMex4; coding META1_4801-META1_4803 Hypothetical protein///transposase
of ISMex4, IS1380 family/conserved
hypothetical protein
META2 426,304 +1205 bp Gain ISMex1; coding META2_0472-META2_0475 Transposase of ISMex1, IS3 family
(ORF 1)/conserved hypothetical
protein
META2 1,153,967 +1620 bp Gain ISMex4; intergenic META2_1243-META2_1245 Transposase of ISMex10, ISL3 family/
transposase of ISMex4, IS1380 family
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Table 1 List of mutations derived in the Modern AM1 lineage (Continued)
Unmapped Archival AM1 DNA
Size (bp) Location(s) Composition
11908 ? Porin protein, transcriptional regulator (AraC) protein, conjugative relaxase domain protein, sodium/hydrogen
exchanger, TraG homolog
8419 META1_4345/META2_0137 TonB-dependent receptor/siderophore receptor protein, hypothetical proteins
8000 META1_1083 Sodium/calcium exchanger, hypothetical proteins
5207 META2_0137 Cold shock protein A (cspA), metallophosphoesterase, plasmid stabilization system, addiction module antidote
protein, cobyrinic acid ac-diamide synthase, stability/partitioning determinant, hypothetical proteins
2423 p2META_0017 Oxidoreductase molybdopterin binding protein, sulfite:cytochrome c oxidase subunit B, hypothetical proteins
35957 Total bp
Mutations were identified by comparing the Archival genome to a previously sequenced Modern reference [21]. By comparing the mutational state (Archival or Modern) at
each site to other previously sequenced strains of M. extorquens (see Methods), all but two mutations can be unambiguously traced as having occurred on the branch from the
Ancestral to Modern AM1 (Figure 1). The effect of nonsynonymous mutations on coding regions are highlighted in bold and italic.
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high-throughput microbial culturing system and analysis
software [27,44]; and relative fitness, which analyzes
performance over multiple phases of bacterial growth
(i.e. lag, exponential, and stationary) using a head-to-
head competition of strains in co-culture [30].
Our initial hypothesis was that Modern AM1 would out-
perform the Archival strain, owing to an increased likeli-
hood of mutations in Modern AM1 that could facilitate
adaptation to laboratory conditions. However, contrary to
our expectations, we found that the Archival strain was
both faster and fitter under most conditions tested. The
Archival strain was considerably faster growing on the C1
compounds methanol (42%) and methylamine (12%), asFigure 2 Archival outperforms Modern AM1 under standard growth con
over time of Modern (black circles) and Archival AM1 (gray squares) cultured u
the exponential phase of cultures grown on methanol (M), methylamine (Ma),
Modern and Archival were calculated using a two-tailed, unpaired t test, and a
Archival AM1 measured via a head-to-head competition mixed in co-cul
growth consisted of unlabeled Modern (black) versus the fluorescent Mo
fitness relative to Modern grown M, Ma, and S. Values are the mean plus
biological replicates (see Methods).well as the multi-C substrate succinate (52%; Figure 2A
and B). In head-to-head fitness competitions, the Archival
strain showed roughly a 30% advantage across the sub-
strates tested (Figure 2C), suggesting that analyses of
growth rate and fitness are not entirely correlated. None-
theless, these results show that the Archival strain outper-
forms Modern under most standard growth conditions,
and suggest that the Modern lineage became slower and
less fit during its time in the lab.
Modern outperforms the Archival AM1 on nutrient broth
We next sought to compare Modern and Archival AM1
using less traditional growth substrates. In contrast to
“Hypho” minimal medium, nutrient broth (NB) is a richditions. A) Representative growth curves showing the increase in OD600
sing 3.5 mM succinate in 48-well plates. B) Growth rates calculated from
or succinate (S) as a carbon source. Significant growth differences between
re marked by single (p < 0.05) and double asterisks (p < 0.01). C) Fitness of
ture with a fluorescently labeled Modern reference. A control
dern reference grown on M. All other bars (gray) show Archival
SEM of growth rates or fitness values calculated from three or more
Figure 3 Modern outperforms Archival AM1 when grown on
nutrient broth. A) Representative growth curves of Modern (black
circles) and Archival (gray squares) AM1 grown on nutrient broth
(NB). Note that growth - particularly for the Archival strain - slows
considerably during late exponential phase, signifying density-dependent
growth inhibition. B) Change in the proportion of either Modern or
Archival AM1 mixed in co-culture with a fluorescently labeled
Modern reference as measured by flow cytometry. Values represent
the mean plus SEM of at least three biological replicates grown in
48-well plates (A) or flasks (B).
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tone), but its exact nutritional components are largely
undefined. Today, NB is rarely used as a growth sub-
strate for Methylobacterium, and is used almost exclu-
sively to support growth in co-cultures with E. coli
during conjugal matings for genetic manipulation. It is
possible, however, that Modern AM1 was more fre-
quently cultured on NB in the past and may have
adapted to growth on this medium. To test this hypoth-
esis, we assessed the growth and fitness of Modern and
Archival AM1 cultured on NB.
We found over multiple different growth experiments
that Modern AM1 consistently outperformed Archival
on NB, although both strains grew more poorly than on
Hypho medium. Modern displayed a clear growth ad-
vantage on NB in 48-well plates (Figure 3A), which
could be traced in part to its relative insensitivity to per-
turbations arising during the later stages of NB growth.
While monitoring the increase in OD600 over time, we
observed that NB cultures tended to slow down during
the later stages of exponential growth, and that the
Archival strain was hindered to a greater extent than
Modern. This suggested that Modern may have adapted
to yet unknown components of growth in NB; however,
due to this decrease during late exponential phase, we
were unable to accurately assess differences in specific
growth rate, and sought instead to quantify performance
using a head-to-head competition of Modern and Arch-
ival co-cultures.
The performance of Archival AM1 co-cultured with a
fluorescently labeled Modern reference was monitored
over the course of several days during growth in NB
flasks. Co-cultures were sampled periodically to monitor
changes in the ratio of nonfluorescent (Archival) to
fluorescent (Modern) cells using flow cytometry. These re-
sults suggest that the Archival AM1 holds an early growth
advantage in NB that quickly decreases from 1 to 4 days
until the strains reach stationary phase (Figure 3B). As a
control, a co-culture of nonfluorescent Modern mixed with
the same fluorescent Modern reference showed little
change over the course of the experiment. Using the ratio
of nonfluorescent to fluorescent cells at the start and the
end of one growth cycle, we can calculate the fitness of the
Archival AM1 relative to Modern assuming a 64-fold (26)
increase in the population (see Methods), and find that
Archival is only 61% as fit as Modern during growth on
NB. Overall, the improved performance of Modern on NB
is suggestive of adaption, either specifically to this medium,
or to yet unknown but similar growth conditions.
Archival and Modern are similar in terms of long-term
growth and storage
Another dimension in which AM1 may have adapted to
life in the lab is through improved performance duringlong-term growth and storage. We compared the Mod-
ern and Archival strains grown for extended periods
both in flasks and on plates by creating co-cultures of
each strain with a fluorescently labeled Modern refer-
ence, and monitoring the change in fluorescent to non-
fluorescent cells over time using flow cytometry. Growth
in flasks was performed over 14 days with continual
shaking using succinate as a growth substrate, while
growth on methylamine plates was carried out at 30°C
for 4 days, followed by up to 60 days at 4°C to simulate
long-term storage.
Here, Modern and Archival AM1 were roughly equiva-
lent in terms of growth and survival during stationary
phase. In flasks, the ratio of unlabeled Archival cells
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the initial 2 days of exponential growth (Figure 4A),
while the unlabeled Modern control remained un-
changed for the duration of the experiment. Archival
held a similar advantage during storage at 4°C on agar
plates for up to 60 days (Figure 4B). Collectively these
results suggest that, at least under these conditions
tested, the extent to which laboratory domestication
improved the long-term growth and survival of AM1
is limited, and that the major difference between these
strains lies in decreased exponential phase growth inFigure 4 Equivalence of AM1 strains during tests of long-term
growth and survival. Co-cultures were created by mixing either
Modern (black circles) or Archival AM1 (gray squares) with a fluorescently
labeled Modern reference, and the change in unlabeled versus fluorescent
cells was monitored over time using flow cytometry. A) In continually
shaken flasks with succinate, the Archival strain increased in frequency
over the first two days of growth and maintained this advantage over
Modern over time. B) Similarly, Archival increased in frequency during four
days of growth on methylamine agar plates (not shown), and maintained
this frequency during long-term storage at 4°C. Values represent the
mean plus SEM of the percent unlabeled cells measured in three
replicate co-cultures.Modern under standard conditions, and slightly in-
creased growth on NB.
Growth of AM1 is significantly hampered by selection for
rifamycin resistance
To explain the decreased performance of Modern AM1
under most growth conditions, we returned to the gen-
omic changes identified in this lineage. All but one of
the 29 mutations arising in Modern AM1 can be attrib-
uted to unintended laboratory domestication; this single
exception, however, was central to the development of
Modern AM1. In 1984, Fulton and colleagues selected
for rifamycin resistance (RifR) to facilitate genetic manip-
ulations in AM1 using conjugative, tri-parental matings
[45]. Across numerous systems, mutations conferring
RifR most often occur in the beta subunit of RNA poly-
merase – encoded by rpoB – and typically give rise to
fitness tradeoffs between survival in the presence of anti-
biotics versus decreased growth in their absence [46].
Compared to the Archival strain, Modern AM1 has two
mutations to the rpoB locus (Table 1), one of which
(Q521R) falls in a region that confers RifR in a variety of
other organisms [47], while the effect of the other
(Q1081R) is yet unknown. At both positions the amino
acid state of the Archival strain is universally shared
with other non-AM1 strains of M. extorquens, suggest-
ing that these mutations arose exclusively in the Modern
lineage. Thus, these mutations to rpoB, particularly
Q521R, are strong candidates for decreased overall
performance in Modern AM1: offering resistance in
the presence of Rif but slower growth in its absence.
To explore the potential costs associated with anti-
biotic resistance, we recapitulated the evolution of RifR
in independent replicate cultures of the Archival strain.
Out of 36 independent populations grown to saturation,
only 7 produced a small number of spontaneous, resist-
ant colonies when plated on Rif agar plates. Each inde-
pendent population was streaked to purity, analyzed in
terms of growth rate on succinate (with no antibiotic),
and sequenced along with the Modern and Archival
strains at the rpoB locus.
Independent experiments recapitulating RifR in the
Archival strain all selected for mutations to rpoB, and all
resulted in decreased growth in the absence of antibiotic.
Upon sequencing rpoB from the 7 newly evolved Arch-
ival isolates, we found that RifR was always associated
with mutations to rpoB. One of these strains (CM4022)
acquired the exact same nonsynonymous change that
occurred in Modern evolution, corroborating our hy-
pothesis that the Q521R mutation (from Archival to
Modern) is causal in conferring RifR to Modern AM1.
Indeed, all mutations observed fall within a region of
rpoB that is commonly mutated to confer RifR across a
variety bacteria [47].
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isolates displayed highly variable effects on growth rate
in the absence of antibiotic. Compared to their Archival
ancestor, several RifR isolates show very little decrease in
performance when grown on succinate, while other iso-
lates slow to near Modern levels, and still others grow
substantially worse than Modern (Figure 5B). Interest-
ingly, the CM4022 isolate that perfectly recapitulated the
change from Archival to Modern AM1 (Q521R) was
slightly faster than Modern, suggesting perhaps that
other mutations further hamper growth in the Modern
lineage. We note, however, that a direct comparison of
this strain is difficult given that many other mutations
and mutational interactions were likely present in Mod-
ern AM1 during the original selection for RifR. Never-
theless, these results demonstrate that selection for RifRFigure 5 Mutations associated with rifamycin resistance hinder
AM1 growth. A) Spectrum of mutations to the RNA polymerase
beta subunit (RpoB) during past and current selection for rifamycin
resistance (RifR). Modern AM1 was selected for RifR in 1984 [45] and
acquired two mutations to RpoB: Q521R, and Q1081R (denoted by
an asterisk). By recapitulating selection for RifR in replicate Archival
populations, we identified a number of other RpoB mutations
putatively associated with RifR. B) The effect of RifR mutations on
growth rate in the absence of antibiotic. Values represent the mean
plus SEM of four biological replicates grown in 48-well plates with
succinate. Strains that were significantly slower than Archival are
marked with asterisks (p < 0.01, one-way ANOVA with Tukey
post-hoc test).can substantially hinder growth of the Archival strain
in the absence of antibiotic, and that this single
researcher-imposed event – not laboratory domestica-
tion - is the major mechanism by which Modern AM1
became slower growing in the lab.
Discussion
This work highlights the surprising extent to which
M. extorquens AM1 has inadvertently diverged during
fifty years of growth and storage in the lab. Compared
to an Archival AM1 strain, our Modern AM1 stock
was slower growing under most standard laboratory
conditions, and one mechanism to account for this
decrease is in past selection for rifamycin resistance.
Indeed, the recapitulation of RifR in independently
evolved populations of the Archival strain frequently,
but not always, led to a tradeoff between survival in
the presence of antibiotic and decreased growth in its
absence. Upon sequencing the Archival genome, we iden-
tified some 29 mutations that have accrued in the Modern
AM1 lineage, including a number of single nucleotide
polymorphisms, small insertions and deletions, the prolif-
eration of mobile elements, and the loss of some 36 kb
of DNA. Though the full impact of these mutations for
improving growth on NB or other conditions has yet to be
revealed, it is clear that Modern AM1 has diverged sub-
stantially through laboratory domestication and changes
stemming from selection for antibiotic resistance.
At first glance, it was not immediately clear why Mod-
ern AM1 had become slower and less fit under standard
growth conditions. Our initial hypothesis was that Mod-
ern would outperform the Archival strain due to the ac-
quisition of mutations that optimized growth or survival
in the laboratory, but our results suggested the contrary.
Alternative hypotheses to account for decreased per-
formance in Modern might include the chance acquisi-
tion of one or more mutations that are deleterious for
growth, or that selection for mutations that improve
growth under certain laboratory conditions generated
tradeoffs in others. In the latter case, a strong candidate
emerged in tradeoffs generated by selection for antibiotic
resistance. Antibiotic resistance in organisms often car-
ries with it a fitness cost in the absence of antibiotic, and
this has been documented in related strains to our Mod-
ern AM1 [48]. We discovered two mutations to rpoB in
our Modern strain: one that is hypothesized to confer
resistance (Q521R), while the effect of the other is yet
unknown but might serve a compensatory function [49].
Reselecting for RifR in 7 independent populations of
Archival AM1 resulted in a variety of mutations to rpoB
with variable effects on growth in the absence of anti-
biotic. One strain in particular (CM4022) perfectly reca-
pitulated the Q521R mutation in Modern AM1, and
yet showed slightly faster growth than Modern despite
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parison of this strain and the original selection for RifR
in Modern AM1 is complicated by the presence of other
mutations in the genetic background of the latter, these
results strongly suggest that selection for RifR was the
major factor affecting growth in the Modern strain.
Given the large number of genomic changes identified
in the Modern lineage (n = 29), it is somewhat surprising
that the only mutation attributed to purposeful labora-
tory selection, and not domestication, accounts for much
of the phenotypic divergence observed between the
Archival and Modern strains.
Though the exact circumstances under which Modern
AM1 evolved cannot in most cases be ascertained, we
can at least hypothesize as to the general factors that
might have played a role. Prior to the widespread use
of −80°C freezers, long-term storage of AM1 cultures was
accomplished using Hypho agar slants with methanol or
methylamine [18,50], most often under refrigeration. A
study of Salmonella [4,5] and E. coli [6-8] archived for
decades under similar conditions revealed a number of
genomic and physiological changes that aid in survival
during long-term stationary phase. These conditions
often select for mutants with a “growth advantage in
stationary phase” (GASP) phenotype associated with
increased catabolism of amino acids and other small
organic compounds, as well as the ability to outcompete
“younger” cultures [51]. Although a GASP-like phenotype
was not observed in the two test environments with which
we compared Modern versus Archival AM1, further
experiments might reveal conditions in which Modern
AM1 has adapted to other facets of laboratory growth
or storage. One particularly interesting direction is in
the advantage of Modern on NB, which may have
evolved specifically to this medium or merely correlate
with improvements in other conditions, such as the
ability to survive long-term growth with limiting nutrients.
Along these lines, we analyzed the growth of RifR strains
(CM4020-26) on NB and found that they performed
equally as well, if not worse, than their Archival parent
strain (data not shown). This suggests that improved
growth of Modern on NB is due to one or more mutations
that arose during laboratory domestication, not through
the rpoB mutation associated with RifR.
Between long periods of storage, Modern AM1 may
have also adapted to yet unknown growth conditions.
The specific components of growth media can act as a
strong selective pressure in microbial cultures [52-54],
and over many years Modern AM1 experienced both
numerous variants of minimal media, as well as occa-
sional growths in rich media like NB. Large populations
of microorganisms competing for limiting resources can
create strong selective pressures for increased growth
rate, which may have accrued in Modern AM1 only tobe partly nullified due to later tradeoffs with RifR. It is
also possible that some mutations were fixed not
through selection for improved performance in labora-
tory conditions, but rather via genetic drift stemming
from practices that result in extreme population bot-
tlenecks, such as colony picking. Given the complex
and overall vague history of Modern AM1 in the lab,
reconstructing the exact mechanisms that drove its
evolution might be best accomplished by studying
other “offshoots” of the laboratory-maintained Modern
lineage, and by characterizing the selective effect of
Modern mutations in the Archival genetic background
using allelic exchange.Conclusions
The laboratory environment affords researchers with a
great degree of control over experimental variables: from
reagents and protocols, to the genotype of their model
microbe, and the environment in which it lives in. Ex-
amples of laboratory domestication, however, highlight
the difficulty of maintaining high quality microbial stocks.
Mutations can jeopardize the integrity of microbial stocks
and, given time, lead to spurious and inconsistent results
stemming from the evolutionary divergence of strains.
Even purposeful laboratory experiments intended merely
to select for antibiotic resistance or otherwise alter the
genetic background of strains can have unanticipated
pleiotropic effects. Thus, extra care should be taken to en-
sure that experimental findings from strains are reprodu-
cible and consistent over time. For those stocks in which
divergence has already occurred, these microbes offer a
unique opportunity to explore genetic and phenotypic
changes resulting from complex evolutionary processes at
work in the lab.Methods
Bacterial strains & growth conditions
Strains relevant to this study were as follows. Our Mod-
ern AM1 strain was derived from a pink, “wildtype” M.
extorquens AM1 (CM501) described elsewhere [23]. A
sample of lyophilized Archival AM1 (renamed CM3944)
was acquired from the National Center of Industrial
Food and Marine Bacteria (NCIMB #9133, Aberdeen,
Scotland), grown to saturation, and frozen at −80°C in
8% DMSO. To limit cell clumping and reduce noise in
OD600 measurements during analyses of growth rate, we
utilized a strain of Modern AM1, CM2720, that lacks
genes for cellulose biosynthesis [27] without a loss of
growth or fitness. For competitions in co-culture, a fluo-
rescently labeled Modern reference (CM1175) was con-
structed by placing the red fluorescent protein mCherry
under control of a constitutive Ptac promoter at the
katA locus [30]. Isolates from each of seven Archival
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below) were numbered CM4020 through CM4026.
Standard growth conditions utilized a modified version
of Hypho minimal medium consisting of: 100 mL phos-
phate salts solution (25.3 g of K2HPO4 plus 22.5 g
Na2HPO4 in 1 L deionized water), 100 mL sulfate salts
solution (5 g of (NH4)2SO4 and 2 g of MgSO4 • 7 H2O
in 1 L deionized water), 799 mL of deionized water, and
1 mL of trace metal solution [55]. All components were
autoclaved separately before mixing under sterile condi-
tions. Carbon sources added just prior to inoculation in
liquid minimal media consisted of 20 mM methanol,
3.5 mM sodium succinate, or 20 mM methylamine
hydrochloride. Growths in 48-well microtiter plates con-
sisted of Hypho medium plus the appropriate carbon
source to a volume of 640 μL. Agar plates consisted of
growth medium plus either 125 mM succinate or
100 mM methylamine and were autoclaved with 1.6% w/v
agar. Difco nutrient broth (Becton, Dickson, and Com-
pany, Franklin Lakes, NJ) was prepared according to the
manufacturer’s guidelines.
All growth regimes consisted of three phases consist-
ing of inoculation, acclimation, and experimentation
growths. All strains were stored in vials at −80°C in 8%
DMSO; growths were initiated by transferring 10 μL
freezer stock into 10 mL of Hypho medium with metha-
nol. Upon reaching stationary phase (~2 days at 30°C
with shaking), cultures were transferred 1:64 into the ap-
propriate medium and vessel to be tested, allowed to
reach saturation in this acclimation phase, and diluted
1:64 again into fresh medium for the measured (experi-
mental) growth.
Measurements of specific growth rate and relative fitness
The increase in OD600 for strains grown in 48-well mi-
crotiter plates was measured using an automated, ro-
botic culturing and monitoring system [27,44]. The
specific growth rate of cultures was calculated from the
log-linear growth phase using custom-designed growth
analysis software [27]. Growth rates reported for each
strain and condition are the mean plus SEM calculated
from triplicate biological replicates, unless otherwise noted.
Exogenous cellulase enzyme from Aspergillus niger (Sigma-
Aldrich, St. Louis, MO) was added to the medium to a final
concentration of 0.1 mg/mL to further minimize cell
clumping and facilitate more accurate measurements of
OD600 over time (SMC, unpublished).
Fitness measurements – which encapsulate the lag, ex-
ponential, and stationary phases of growth – were per-
formed using a head-to-head competition of strains
grown in co-culture [30]. Modern and Archival AM1
were competed against a fluorescently labeled Modern
strain (CM1175) expressing mCherry [30]. Co-cultures
were prepared by mixing test strains with the fluorescentModern reference in roughly equal optical densities. A
sample of this co-culture prior to competition was di-
luted in 8% DMSO and stored at −80°C; the rest was di-
luted 1:64 into 640 μL Hypho medium plus carbon in
48-well microtiter plates and incubated with shaking at
30°C for 1 growth cycle. A sample of co-culture after
competition was frozen for later analysis using flow
cytometry.
The ratio of labeled to unlabeled cells in co-cultures
before (R0) and after (R1) competition was measured
using a BD LSR Fortessa flow cytometer with an HTS at-
tachment (BD Biosciences, San Jose, CA). Both forward
and side scatter settings were set to 300 V to account
for the small size of bacterial cells [56], and the flow-
rate was adjusted to the lowest setting to more accur-
ately identify events (cells) in dilute co-cultures. The
fitness (W) of strains relative to the labeled Modern
reference was calculated using the following formula,
which assumes a 64-fold expansion of cells following 6
doublings per growth cycle:
W ¼ log R1⋅ 64
R0
 
= log
1−R1ð Þ⋅64
1−R0
 
Analysis of long-term growth and storage
To assess the ability of strains to withstand extended pe-
riods of stationary phase growth in flasks, Modern and
Archival AM1 were mixed in co-culture with the fluorescent
Modern reference, and the ratio of labeled to unlabeled cells
was measured periodically using flow cytometry. Flasks pos-
sessing succinate were sealed to limit evaporation, and at
the conclusion of the experiment co-cultures were streaked
onto nutrient agar plates to check for contamination.
Growth and survival on plates was measured using a similar
experimental design: co-cultures were spread onto Hypho
plus methylamine plates, grown for 4 days at 30°C, and then
stored at 4°C for up to 60 days with periodic sampling.Recapitulation of Rif resistance in AM1
The re-evolution of Rif resistance in Archival AM1 was
performed using 36 replicate lineages grown from single
colonies in 48-well plates. After 2 days growth in liquid
Hypho medium plus succinate, cultures were plated
without dilution onto Hypho agar plus succinate plates
containing 50 μg/mL Rif. After 5 days of growth, RifR
colonies were obtained from 7/36 cultures and streaked
twice more to ensure the purity of clonal isolates
(CM4020-4026). PCR amplification plus sequencing was
used to assess mutations to the rpoB locus and the
growth rate of strains on succinate was determined as
described above.
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Preparation of Archival genomic DNA was performed as
described in [57]. Briefly, an Archival cell pellet was
lysed using bead beating (MP Biomedicals, Solon, OH)
and digested using heat, SDS and Triton-X100 deter-
gents, proteinase K, and RNase A. Cell debris was pre-
cipitated with CTAB/NaCl, removed using a phenol/
chloroform/isoamyl alcohol extraction, and genomic
DNA recovered using an isopropanol precipitation. Illu-
mina HiSeq2000 sequencing was performed out-of-
house using GENEWIZ, Inc (South Plainfield, NJ). A
total of 23,660,656 reads were generated, and 98.2% of
these were mapped against the Modern AM1 reference
[21] using breseq v0.21 [58] with Bowtie 2 version 2.0.0-
beta7 [59]. To identify DNA lost in Modern AM1 evolu-
tion, reads that were unmapped using breseq were
analyzed using ABySS v1.3.4-kmer-96 [60] for de novo
assembly of contigs,. A full de novo assembly of the
Archival genome was also performed in ABySS for com-
parison against breseq. Contigs from ABySS were further
assembled and curated using contig assembly and
BLAST in Geneious [61]. To determine whether muta-
tional differences occurred in either the Modern or
Archival lineage, we compared the mutational state
(Archival or Modern) at each site to other previously
sequenced strains of M. extorquens using both BLAST
and analyses of conserved gene synteny using the
Methyloscope project in MicroScope [62]. Mutations were
identified as “derived” in the Modern lineage if the Archival
state was consistently shared across related strains, to the ex-
clusion of Modern AM1. Related strains included M. extor-
quens PA1 (GenBank Assembly ID: GCA_000018845.1),
CM4 (GCA_000021845.1), DM4 (GCA_000083545.1), and
DSM 13060 (GCA_000243435.2). For all loci but two, the
Archival state was universally conserved; the only exceptions
were for genes with little to no homology outside of Modern
and Archival AM1.
Availability of supporting data
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